Emami logo

Emami share news, announcements and annual reports

NSE: EMAMILTDBSE: 531162Personal ProductsSmall Cap

Emami Limited · Face value ₹1 · Listed Oct 1995 on BSE, Aug 2006 on NSE
Last close ₹359.75down ₹11.15 (3.01%)BSE ₹359.85

Share price at the NSE close on 30 Oct 2026. Previous close ₹370.90.

30 Oct: open ₹371.10, high ₹371.50, low ₹357.00

52-week range of traded prices to 30 Oct 2026
₹357.00Low, 30 Oct 2026₹550.90High, 16 Dec 2025
Market cap
₹15,440 Cr349th largest listed
P/E
20.63
P/B
5.28
Dividend yield
2.78%
ROE
26.6%
ROCE
26.3%
Debt to equity
0.04
Volume, NSE
7,11,12257.5% delivered

Emami orders, deals and press releases

98 filed, newest first. Page 2 of 2.

  1. Aug 2021

  2. Jun 2021

  3. May 2021

  4. Nov 2020

  5. Aug 2020

  6. Jun 2020

  7. May 2020

  8. Apr 2020

  9. Feb 2020

  10. Nov 2019

  11. Aug 2019

  12. Jun 2019

  13. May 2019

  14. Apr 2019

  15. Feb 2019

  16. Jan 2019

  17. Oct 2018

  18. Aug 2018

  19. May 2018

  20. Jan 2018

  21. Oct 2017

  22. Jan 2017

  23. Oct 2016

  24. Aug 2016

  25. May 2016

  26. Jan 2016

  27. Oct 2015

  28. Aug 2015

  29. Jun 2015

  30. May 2015

  31. Feb 2015

  32. Jan 2015

  33. Oct 2013

  34. Jul 2013

    • 1 Jul · Business

      Pursuant to the approval given by the Shareholders through Postal Ballot under Section 192A of the Companies Act 1956 on June 17, 2013 for issue of Bonus Shares in the ratio of one new Bonus share for every two equity shares held by the existing shareholders on the Record date i.e. on June 27, 2013 as fixed by the Company, the Share Transfer Committee of the Company as authorized by the Board has allotted 7,56,55,873 Equity Shares of Re.1/- each as Bonus Shares on June 28, 2013.
  35. Jan 2011

    • 28 Jan · Business

      Emami Overseas FZE a step down wholly owned subsidiary Company has acquired 1926 Equity Shares i.e. 90.59% Share Capital of M/s. Pharma Derm S A E Co, Egypt a Company incorporated under the Laws of Egypt. By virtue of above acquisition of share capital and management control of the aforesaid Company, M/s Pharma Derm S A E co, Egypt has become a subsidiary of the Company.
  36. Dec 2009

    • 3 Dec · Business

      Hon'ble Calcutta High Court has approved the Scheme of Arrangement under section 391 to 394 of the Companies Act 1956, between Emami Ltd, The Zandu Pharmaceuticals Workers Ltd and Emami Infrastructure Ltd on 17th November 2009 and certified copy of the said Order has been filed with the Registrar of Companies, West Bengal on 2nd December 2009 to make the scheme effective.
  37. Sep 2009

    • 17 Sep · Business

      At the meeting of the Equity Shareholders of the Company held on September 11, 2009 convened on the direction of the High Court of Calcutta, the shareholders have approved the Scheme of Arrangement in terms of Section 391 to 394 of the Companies Act, 1956 between Emami Ltd, The Zandu Pharmaceutical Works Ltd and Emami Infrastructure Ltd.
  38. Jul 2009

    • 2 Jul · Business

      Qualified Institutional Placement (QIP) of Emami Limited of Equity Shares of Rs.2/- each as determined by the Book Building Process under "Chapter XIIIA - Guidelines for Qualified Institutional Placement" of the SEBI (Disclosure and Investor Protection) Guidelines, 2000, as follows: "The duly authorised committee of the Board of Directors viz. Share Transfer and Shareholders / Investors Grievance Committee, at its meeting held on July 2, 2009 has decided to close the issue and has approved the issuance of 1,00,00,000 (One Crore) Equity Shares of Rs.2/- each for cash at a price Rs.310/- per Equity Share (including a premium of Rs. 308/- per Equity Share) aggregating to Rs.310/- Crore (Rupees Three Hundred and Ten Crore only)".
  39. Oct 2008

    • 16 Oct · Business

      Vide its letter dated October 15, 2008, that: "Pursuant to the settlement efforts initiated by the Hon'ble Company Law Board vide its order dated 22nd September, 2008, the Company has acquired, in terms of a Share Purchase Agreement entered with the existing promoters of The Zandu Pharmaceuticals Works Limited (Zandu) and their relatives, friends and associates, 146643 equity shares comprising of 18.18% of the total paid up capital of Zandu at a price of Rs 15,000/- (Rupees Fifteen Thousand only) per share and also a non compete fee of Rs 1500/- (Rupees One Thousand five hundred only) per equity share. Please be further informed that by separate transactions, the company has today further acquired 37417 Equity shares of Zandu, as per details given herein under: i) No of Shares - 4103; % of paid up Equity Capital - 0.51%; Price per share - 14440.90. ii) No of Shares - 33314; % of paid up Equity Capital - 4.13%; Price per share - 14356.65".
  40. May 2008

    • 30 May · Business

      The Company has entered into the Share Purchase Agreement with some of the existing promoters of The Zandu Pharmaceuticals Works Limited for acquiring 1,02,409 Equity Shares i.e. 12.70% of the said Company. Consequent to the above, the aggregate shareholding of the Company alongwith its associate / group companies / PACs in The Zandu Pharmaceuticals Works Limited has become 27.51% of the equity share capital of said Company which obligates the company to give Open Offer for acquiring minimum 20% shares from the Public pursuant to the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The Company has decided to make an Open Offer to all the remaining equity shareholders of The Zandu Pharmaceuticals Works Limited for acquiring 1,61,280 Equity Shares i.e. 20% of the paid up equity share capital of the Target Company
  41. Apr 2007

    • 11 Apr · Business

      Emami Limited had informed the Exchange about sanction of the Scheme of Amalgamation of J.B.Marketing & Finance Ltd. with the company by Hon'ble Calcutta High Court. The Company has now informed the Exchange that "The said scheme of amalgamation has been effective from 1.4.2006".
  42. Mar 2007

    • 2 Mar · Business

      The Hon'ble Calcutta High Court has sanctioned the Scheme of Amalgamation of J B Marketing & Finance Limited with the Company on 23rd February 2007